GlassScriptPhysician profile
Chad Christopher Greer
NPI 1063629392
$221.94
in general payments reported to CMS, 2019-2025
9 companies · $23.88 in 2025
The $23.88 reported for 2025 was less than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.80 · 2021: $15.25 · 2022: $20.23 · 2023: $121 · 2024: $23.46 · 2025: $23.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $42.85 | 2023 | Ethicon, Stratafix, Dermabond Prineo |
| Si-Bone, INC. | $35.28 | 2023 | |
| Horizon Therapeutics Plc | $31.22 | 2019-2023 | Krystexxa |
| Fidia Pharma USA INC. | $23.88 | 2025 | Triluron, Hymovis |
| Bioventus LLC | $23.46 | 2024 | Durolane |
| Smith+Nephew, INC. | $20.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.25 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.93 | 2023 | Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $14.84 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.